At GoalBMI Wellness, Karla works with eligible patients exploring GLP-1 and GIP weight loss programs, peptide therapy, hormone optimization, metabolic wellness, and personalized treatment plans through secure telehealth consultations
Canadian Regulatory Context BPC-157 has not been approved for human medical use by Health Canada or any other major regulatory body, including the U.S
Incidence of esophageal adenocarcinoma in Barretts esophagus with low-grade dysplasia: a systematic review and meta-analysis
By suppressing TGF-1 expression and preventing Smad2/3 phosphorylation, luteolin downregulates core ECM components, such as collagen I, fibronectin, and alpha-smooth muscle actin (-SMA), thereby limiting myofibroblast activation and pathological ECM accumulation
below body temperature, at about 3 C
This had no impact on the peer review process and the final decision